FREE USPS SHIPPING OVER $150Order by 12 PM Pacific Time for same-day shippingSpend $300, get a free Retatrutide 10mg or Wolverine 10mg (BPC-157 5mg + TB-500 5mg) · ends Nov 30

Home / Guides / documentation

CJC-1295 Ipamorelin Blend Composition, Molecule by Molecule

documentationUpdated 2026-09-29Reviewed by Mike Vance, Chief Research OfficerResearch use only
CJC-1295 (no DAC)+IPA research vial with its LabFirst lot label
Short answer

A CJC-1295 ipamorelin blend holds two synthetic peptides dried into one vial. One is CJC-1295 without DAC, a modified 29-residue GRF(1-29) chain at 3367.9 g/mol. The other is ipamorelin, a five-residue peptide at 711.9 g/mol. Our 10 mg vial lists the total; the lot certificate states the amount of each.

Key facts
  • CP10 is a single 10 mg vial holding CJC-1295 no DAC and ipamorelin together.
  • CJC-1295 no DAC is a modified 29-residue GRF(1-29) amide, C152H252N44O42, 3367.9 g/mol.
  • Ipamorelin is a pentapeptide, C38H49N9O5, 711.9 g/mol, PubChem CID 9831659.
  • The DAC is an albumin-bonding maleimido group this blend's CJC-1295 does not carry.
  • The LabFirst catalog states the CP10 blend total only; the lot certificate states each component amount.
  • In a CJC-1295 ipamorelin blend, equal masses would mean about 4.7 ipamorelin molecules per CJC-1295 molecule.

Two peptides sharing a vial

What is actually in there? Two different molecules, one large and one small, that were dissolved together and then freeze-dried into a single white cake. Nothing links them chemically. They simply share the glass. Picture the vial as one envelope holding two separate letters.

The product here is SKU CP10, listed as CJC-1295 (no DAC)+IPA, 10 mg total. Both components are also sold on their own, as CJC-1295 no DAC and ipamorelin, which makes it easy to compare each part of the blend with its single-compound record.

This page is about composition only. For buying checks see the CJC-1295 ipamorelin blend buying guide, and for temperatures the storage temperature reference.

At a glanceWhat makes up the blend vial
  • CJC-1295 without DAC, 29 residues, 3367.9
  • Ipamorelin, five residues, 711.9
  • No chemical link between the two
  • Total of 10 mg printed on the label
  • Per-component milligrams on the lot certificate
  • Counterion and water inside the powder weight

The larger component: CJC-1295 without DAC

CJC-1295 as first published is not quite the molecule in this vial. The Jette paper in Endocrinology identified CJC-1295 as a derivative of hGRF(1-29) carrying a maleimido group, the drug affinity complex or DAC, placed so it would bond to albumin. The no DAC material is the peptide chain without that group, often sold as modified GRF(1-29).

Its frame comes from human growth hormone releasing hormone. The UniProt record for that hormone shows a 108-residue precursor with the mature peptide cut from positions 32 to 75, and the first 29 residues of that mature peptide are the starting point. Our chemistry records describe the no DAC chain as that 29-residue amide with four substitutions, formula C152H252N44O42 and average mass 3367.9.

PubChem has no record for this molecule under any name we tried, so the formula comes from the developer literature and the mass is calculated from it.

The smaller component: ipamorelin

Ipamorelin is a pentapeptide, as Raun and colleagues described it in the European Journal of Endocrinology. PubChem lists it as C38H49N9O5 with an average mass of 711.9 and a monoisotopic mass of 711.386.

Its PubChem name spells out the five building blocks. Reading from the N-terminus, the IUPAC way: an aminoisobutyric acid unit, histidine, a 2-naphthylalanine in the D form, phenylalanine in the D form, and lysine finished as an amide. Three of those five are not among the twenty standard amino acids or appear in their mirror-image form.

Those unusual units matter for testing, because the D-form residues cannot be confirmed by mass alone.

The two side by side

Components of the CJC-1295 no DAC + ipamorelin blend
PropertyCJC-1295 no DACIpamorelin
Residues295
FormulaC152H252N44O42C38H49N9O5
Average mass3367.9711.9
PubChem recordNone foundCID 9831659
C-terminusAmideAmide
SulfurNoneNone

The size gap is the most useful fact on the table. The CJC-1295 component is roughly 4.7 times heavier per molecule, and that shapes everything from how the vial is tested to how its label should be read.

How much of each peptide is in 10 mg?

Our catalog gives the total, 10 mg, and not the split. Rather than print a ratio the records do not support, we leave that to the lot certificate, which should state milligrams of each component.

When you do see a split, check what kind of ratio it is. A mass ratio and a molecule ratio are different claims. If a vial held equal milligrams of each, it would contain about 4.7 ipamorelin molecules for every CJC-1295 molecule, because the smaller molecule weighs so much less.

The label also refers to powder, and powder includes counterion and some water along with the peptides. The net peptide content guide explains how that fraction is measured.

What the blend name does not tell you

CJC-1295 ipamorelin is a trade description, not a defined substance. No pharmacopeial monograph sets its composition, so two suppliers can use the same name for different splits and both describe their own product accurately.

The name also invites a specific mix-up. CJC-1295 with DAC and without DAC are different molecules, and sermorelin, unmodified GRF(1-29) at 3357.9 in PubChem, sits only about ten daltons from the no DAC chain. A blend listing that says only CJC-1295 has not said which of these is in the vial.

The composition is fixed by the documents, not by the name: a formula and a mass for each component, and an amount for each.

How are the contents confirmed?

A laboratory separates the two peptides by liquid chromatography and weighs each by mass spectrometry, looking for a mass near 3367.9 and another near 711.9. Purity and content are then reported per component.

The three companion pages go into detail: reading the blend certificate, how identity is confirmed, and storage and stability.

LabFirst shows results only once the certificate for that lot is published. Nothing on this page reports a result for any of our lots. Published certificates appear through the certificate lookup page and on the CJC-1295 no DAC + ipamorelin product page.

Reading the product label

The label on a CP10 vial is short by design. It names the blend, gives the 10 mg total and carries a lot number. The lot number is the most important of the three, because it is the link to the certificate that holds everything the label leaves out.

Write the lot number down when the vial arrives. If the vial is ever separated from its box, that number is the only way to connect it back to its test results. Ending the chain of records at the vial is the most common way good documentation gets lost.

The words for laboratory research use on the label are a statement about what the material is supplied for. They tell you nothing about composition, which is the job of the certificate.

Why the two are sold together

The two components are chemically unrelated. One is built on the GHRH frame from UniProt P01286, and the other is a short synthetic pentapeptide with three nonstandard building blocks. They reach the same vial because researchers who work with one often work with the other, and a single vial saves a step at the bench.

That convenience comes with a cost in documentation. A single-compound vial needs one identity result and one purity figure. A blend needs two of each plus an amount for each, and a reader has to check more rows before trusting the label.

Buying the two separately gives full control over the ratio in a laboratory solution. Buying the blend means accepting the ratio fixed at filling, which is exactly why that ratio should be written on the certificate.

How the vial is made, in outline

Each peptide is synthesized on its own, purified, and characterized. The two are then dissolved together at the intended proportions, filled into vials, and freeze-dried so the water leaves and a dry cake remains. The stopper is seated under controlled conditions to keep moisture out.

That sequence explains two things about the finished product. First, each component carries its own synthesis impurities from before blending, so purity must be judged per component. Second, the cake contains everything that was in the solution, including counterions from purification, which is why net peptide content is reported separately from the label weight.

The lyophilized peptide guide explains the drying step in more detail.

Checking the name against the chemistry

Three quick checks cover most labeling errors. Does the listing say no DAC explicitly? Does the certificate report a mass near 3367.9 and not 3357.9, which would be sermorelin? And does it report a second mass near 711.9 for ipamorelin?

If all three hold, the vial holds what the name says. If any fails, the name and the contents disagree, and the contents win. Our types of peptides guide shows how modified and unmodified chains like these are classified.

A certificate that answers all three with printed figures is worth more than any product description, including this one.

Regulatory position

Neither component in this blend, and not the blend itself, has a United States pharmacopeial monograph. It is sold as a research chemical, and the release specification for each lot is the supplier's own.

FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

What is CJC-1295 (no DAC)+IPA studied for?

Published research on CJC-1295 (no DAC)+IPA investigates the areas below, which is a different question from what CJC-1295 (no DAC)+IPA will do for anyone, a claim about a living system that nothing on this site is sold for.

What it is. A GHRH copy and a growth-hormone releaser, freeze-dried together in one vial.

What the research looks at. The ingredients appear separately in hormone research. The blend as sold is a way of packaging them rather than something anyone has studied.

How it is thought to work. Two molecules working on two different receptors: CJC-1295 (no DAC) on the GHRH receptor, ipamorelin on the ghrelin receptor. See each ingredient’s own record. Putting them together does not create a third mechanism.

What is not established. No approved product for either ingredient or for the combination. A vial holding two compounds has to be stored to suit the fussier one, and CJC-1295 is the fussier one here.

The full record, including the certificate for the lot in stock, is on the CJC-1295 (no DAC)+IPA product page.

Common questions

What two peptides are in the CJC-1295 ipamorelin blend?

CJC-1295 without DAC, a modified 29-residue GRF(1-29) chain with formula C152H252N44O42 and average mass 3367.9, and ipamorelin, a five-residue peptide listed in PubChem as C38H49N9O5 at 711.9. They are dried together in one vial but are not chemically joined.

Is the CJC-1295 in this blend the DAC version?

No. This product uses CJC-1295 without DAC. The DAC is a maleimido group the original CJC-1295 carries so it can bond to albumin. The no DAC peptide lacks that group and is a much smaller molecule, often called modified GRF(1-29).

How many milligrams of each peptide does the 10 mg vial contain?

Our catalog lists the 10 mg total but not the split, so we do not state one. The certificate for each lot is where milligrams of each component should appear. Any ratio you see should say whether it is by mass or by number of molecules.

Why does the molecule ratio differ from the mass ratio?

Because the CJC-1295 component weighs about 4.7 times as much per molecule as ipamorelin. Equal milligrams of each would mean roughly 4.7 ipamorelin molecules for every CJC-1295 molecule. Documents sometimes blur the two, so it is worth checking which one is meant.

Published certificates for CJC-1295 (no DAC)+IPA

Every figure below is read from a report the laboratory issued for that lot; each page carries the PDF and the lab's own verification link.

Sources

FROM THE BENCH

Lot reports, storage data, and what we learn testing them.

A short note when new certificates post, when a stability result surprises us, and when a guide worth reading goes up. No promotions.

Research correspondence only. Unsubscribe in one click. We never sell or share an address.

Shop the compounds

CJC-1295 Ipamorelin Blend Composition, Molecule by Molecule research vial, supplied with lot-specific documentationCJC-1295 no DACSizes, price per mg and lot certificateCJC-1295 Ipamorelin Blend Composition, Molecule by Molecule research vial, supplied with lot-specific documentationipamorelinSizes, price per mg and lot certificateCJC-1295 Ipamorelin Blend Composition, Molecule by Molecule research vial, supplied with lot-specific documentationCjc 1295 No Dac IpaSizes, price per mg and lot certificateCJC-1295 Ipamorelin Blend Composition, Molecule by Molecule research vial, supplied with lot-specific documentationRetatrutideSizes, price per mg and lot certificateCJC-1295 Ipamorelin Blend Composition, Molecule by Molecule research vial, supplied with lot-specific documentationTirzepatideSizes, price per mg and lot certificateCJC-1295 Ipamorelin Blend Composition, Molecule by Molecule research vial, supplied with lot-specific documentationSemaglutideSizes, price per mg and lot certificate
Browse all compounds